Annual Shareholders Equity
$8.04 M
+$4.99 M+164.00%
31 August 2024
Summary:
Lexaria Bioscience annual stockholders equity is currently $8.04 million, with the most recent change of +$4.99 million (+164.00%) on 31 August 2024. During the last 3 years, it has fallen by -$5.23 million (-39.42%). LEXX annual shareholders equity is now -39.42% below its all-time high of $13.27 million, reached on 31 August 2021.LEXX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$8.04 M
-$2.09 M-20.61%
31 August 2024
Summary:
Lexaria Bioscience quarterly stockholders equity is currently $8.04 million, with the most recent change of -$2.09 million (-20.61%) on 31 August 2024. Over the past year, it has increased by +$4.29 million (+114.73%). LEXX quarterly shareholders equity is now -39.42% below its all-time high of $13.27 million, reached on 31 August 2021.LEXX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEXX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +164.0% | +114.7% |
| 3 y3 years | -39.4% | -31.2% |
| 5 y5 years | +237.2% | +218.2% |
LEXX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -39.4% | +164.0% | -31.2% | +164.0% |
| 5 y | 5 years | -39.4% | +237.2% | -39.4% | +327.9% |
| alltime | all time | -39.4% | +2921.2% | -39.4% | +6558.2% |
Lexaria Bioscience Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2024 | $8.04 M(+164.0%) | $8.04 M(-20.6%) |
| May 2024 | - | $10.12 M(+55.2%) |
| Feb 2024 | - | $6.52 M(+74.2%) |
| Nov 2023 | - | $3.74 M(+22.9%) |
| Aug 2023 | $3.04 M(-61.7%) | $3.04 M(-30.7%) |
| May 2023 | - | $4.40 M(-11.6%) |
| Feb 2023 | - | $4.97 M(-20.6%) |
| Nov 2022 | - | $6.26 M(-21.2%) |
| Aug 2022 | $7.95 M(-40.1%) | $7.95 M(-13.4%) |
| May 2022 | - | $9.18 M(-19.8%) |
| Feb 2022 | - | $11.46 M(-1.9%) |
| Nov 2021 | - | $11.68 M(-11.9%) |
| Aug 2021 | $13.27 M(+425.3%) | $13.27 M(+28.2%) |
| May 2021 | - | $10.34 M(-12.1%) |
| Feb 2021 | - | $11.77 M(+526.7%) |
| Nov 2020 | - | $1.88 M(-25.6%) |
| Aug 2020 | $2.53 M(+6.0%) | $2.53 M(-20.8%) |
| May 2020 | - | $3.19 M(+69.5%) |
| Feb 2020 | - | $1.88 M(-25.6%) |
| Nov 2019 | - | $2.53 M(+6.0%) |
| Aug 2019 | $2.38 M(-0.2%) | $2.38 M(-25.0%) |
| May 2019 | - | $3.18 M(+14.4%) |
| Feb 2019 | - | $2.78 M(-18.6%) |
| Nov 2018 | - | $3.41 M(+43.0%) |
| Aug 2018 | $2.39 M(-20.6%) | $2.39 M(-9.4%) |
| May 2018 | - | $2.64 M(-4.9%) |
| Feb 2018 | - | $2.77 M(+15.4%) |
| Nov 2017 | - | $2.40 M(-20.1%) |
| Aug 2017 | $3.01 M(+1030.2%) | $3.01 M(-7.9%) |
| May 2017 | - | $3.26 M(+372.4%) |
| Feb 2017 | - | $691.20 K(-14.3%) |
| Nov 2016 | - | $806.70 K(+203.3%) |
| Aug 2016 | $266.00 K(-65.6%) | $266.00 K(+120.4%) |
| May 2016 | - | $120.70 K(-54.5%) |
| Feb 2016 | - | $265.00 K(-42.9%) |
| Nov 2015 | - | $463.80 K(-40.0%) |
| Aug 2015 | $772.40 K | $772.40 K(-33.0%) |
| May 2015 | - | $1.15 M(+0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | $1.14 M(-19.1%) |
| Nov 2014 | - | $1.42 M(-60.1%) |
| Aug 2014 | $1.72 M(-18.2%) | - |
| July 2014 | - | $3.55 M(-4.9%) |
| Apr 2014 | - | $3.73 M(+84.1%) |
| Jan 2014 | - | $2.03 M(-3.4%) |
| Oct 2013 | $2.10 M(-13.3%) | $2.10 M(-5.7%) |
| July 2013 | - | $2.23 M(-1.6%) |
| Apr 2013 | - | $2.26 M(-2.1%) |
| Jan 2013 | - | $2.31 M(-4.6%) |
| Oct 2012 | $2.42 M(-9.0%) | $2.42 M(+1.4%) |
| July 2012 | - | $2.39 M(+2.9%) |
| Apr 2012 | - | $2.32 M(-9.1%) |
| Jan 2012 | - | $2.55 M(-4.1%) |
| Oct 2011 | $2.66 M(+23.6%) | $2.66 M(+11.4%) |
| July 2011 | - | $2.39 M(+23.5%) |
| Apr 2011 | - | $1.93 M(-6.5%) |
| Jan 2011 | - | $2.07 M(-4.0%) |
| Oct 2010 | $2.15 M(-6.3%) | $2.15 M(-2.3%) |
| July 2010 | - | $2.21 M(+1.4%) |
| Apr 2010 | - | $2.17 M(-7.0%) |
| Jan 2010 | - | $2.34 M(+1.7%) |
| Oct 2009 | $2.30 M(-16.8%) | $2.30 M(-6.7%) |
| July 2009 | - | $2.46 M(+2.3%) |
| Apr 2009 | - | $2.41 M(-7.4%) |
| Jan 2009 | - | $2.60 M(-5.9%) |
| Oct 2008 | $2.76 M(-18.6%) | $2.76 M(-9.3%) |
| July 2008 | - | $3.05 M(+7.3%) |
| Apr 2008 | - | $2.84 M(-15.3%) |
| Jan 2008 | - | $3.35 M(-1.3%) |
| Oct 2007 | $3.39 M(+381.8%) | $3.39 M(+26.9%) |
| July 2007 | - | $2.68 M(+14.4%) |
| Apr 2007 | - | $2.34 M(-4.7%) |
| Jan 2007 | - | $2.45 M(+248.4%) |
| Oct 2006 | $704.60 K(-35.3%) | $704.60 K(-35.3%) |
| July 2006 | - | $1.09 M(-4.0%) |
| Apr 2006 | - | $1.14 M(-2.6%) |
| Jan 2006 | - | $1.17 M |
| Oct 2005 | $1.09 M | - |
FAQ
- What is Lexaria Bioscience annual stockholders equity?
- What is the all time high annual shareholders equity for Lexaria Bioscience?
- What is Lexaria Bioscience annual shareholders equity year-on-year change?
- What is Lexaria Bioscience quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly shareholders equity year-on-year change?
What is Lexaria Bioscience annual stockholders equity?
The current annual shareholders equity of LEXX is $8.04 M
What is the all time high annual shareholders equity for Lexaria Bioscience?
Lexaria Bioscience all-time high annual stockholders equity is $13.27 M
What is Lexaria Bioscience annual shareholders equity year-on-year change?
Over the past year, LEXX annual stockholders equity has changed by +$4.99 M (+164.00%)
What is Lexaria Bioscience quarterly stockholders equity?
The current quarterly shareholders equity of LEXX is $8.04 M
What is the all time high quarterly shareholders equity for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly stockholders equity is $13.27 M
What is Lexaria Bioscience quarterly shareholders equity year-on-year change?
Over the past year, LEXX quarterly stockholders equity has changed by +$4.29 M (+114.73%)